These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
133 related items for PubMed ID: 11730567
1. Relationship of symptomatology, gender, and antipsychotic drug treatment with plasma homovanillic acid in schizophrenia. Zhang ZJ, Reynolds GP, Ramchand C, Peet M, Shah S. Acta Pharmacol Sin; 2001 Jan; 22(1):76-80. PubMed ID: 11730567 [Abstract] [Full Text] [Related]
8. Relations of clinical features, subgroups and medication to serum monoamines in schizophrenia. Oades RD, Klimke A, Henning U, Rao ML. Hum Psychopharmacol; 2002 Jan 13; 17(1):15-27. PubMed ID: 12404703 [Abstract] [Full Text] [Related]
11. Switching antipsychotics to aripiprazole or blonanserin and plasma monoamine metabolites levels in patients with schizophrenia. Miura I, Shiga T, Katsumi A, Kanno-Nozaki K, Mashiko H, Niwa S, Yabe H. Hum Psychopharmacol; 2014 Mar 13; 29(2):199-202. PubMed ID: 24590545 [Abstract] [Full Text] [Related]
12. An open study of risperidone liquid in the acute phase of schizophrenia. Yoshimura R, Nakamura J, Shinkai K, Goto M, Yamada Y, Kaji K, Kakihara S, Ueda N, Kohara K, Ninomiya H, Egami H, Maeda H. Hum Psychopharmacol; 2005 Jun 13; 20(4):243-8. PubMed ID: 15830401 [Abstract] [Full Text] [Related]
16. D-serine serum levels in patients with schizophrenia: relation to psychopathology and comparison to healthy subjects. Hons J, Zirko R, Ulrychova M, Cermakova E, Libiger J. Neuro Endocrinol Lett; 2008 Aug 13; 29(4):485-92. PubMed ID: 18766161 [Abstract] [Full Text] [Related]
17. Relationship between plasma homovanillic acid and outcome in patients with psychosis spectrum disorders. van de Kerkhof NW, Fekkes D, van der Heijden FM, Egger JI, Verhoeven WM. Neuropsychobiology; 2015 Aug 13; 71(4):212-7. PubMed ID: 26279280 [Abstract] [Full Text] [Related]
18. Predictors of clinical outcome in schizophrenic patients responding to clozapine. Mauri MC, Volonteri LS, Dell'Osso B, Regispani F, Papa P, Baldi M, Bareggi SR. J Clin Psychopharmacol; 2003 Dec 13; 23(6):660-4. PubMed ID: 14624196 [Abstract] [Full Text] [Related]
19. Sex differences in plasma homovanillic acid levels in schizophrenia and normal controls: relation to neuroleptic resistance. Sumiyoshi T, Hasegawa M, Jayathilake K, Meltzer HY. Biol Psychiatry; 1997 Mar 01; 41(5):560-6. PubMed ID: 9046988 [Abstract] [Full Text] [Related]
20. Oxidative mechanisms in schizophrenia and their relationship with illness subtype and symptom profile. Pazvantoglu O, Selek S, Okay IT, Sengul C, Karabekiroglu K, Dilbaz N, Erel O. Psychiatry Clin Neurosci; 2009 Oct 01; 63(5):693-700. PubMed ID: 19788631 [Abstract] [Full Text] [Related] Page: [Next] [New Search]